MALAT1 and chronic kidney disease: No difference of lnc-MALAT1 expression was found between hyperlipidemia patients and non-hyperlipidemia patients (P=0.391) (Figure 4C), hyperuricemia patients and non-hyperuricemia patients (P=0.657) (Figure 4D), or CKD patients and non-CKD patients (P=0.264) (Figure 4E).